Showing results (81-90 of 26,721) with videos related to
Sort By:
Pageof 2,673
Frontiers in Oncology|April 8, 2022
PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted TherapyQian Luo, Ruijuan Du, Wenting Liu, et al.Journal of Molecular Medicine (Berlin, Germany)|June 8, 2014
Glycolytic genes in cancer cells are more than glucose metabolic regulatorsZhe-Yu Hu, Lanbo Xiao, Ann M Bode, et al.The Journal of Biological Chemistry|November 16, 2002
NS-398 and piroxicam suppress UVB-induced activator protein 1 activity by mechanisms independent of cyclooxygenase-2Guangming Liu, Wei-Ya Ma, Ann M Bode, et al.Signal Transduction and Targeted Therapy|February 22, 2024
Protein translation: biological processes and therapeutic strategies for human diseasesXuechao Jia, Xinyu He, Chuntian Huang, et al.The Journal of Biological Chemistry|January 5, 2002
Phosphorylation of 4E-BP1 is mediated by the p38/MSK1 pathway in response to UVB irradiationGuangming Liu, Yiguo Zhang, Ann M Bode, et al.The Journal of Biological Chemistry|November 28, 2001
Requirement of ATM in UVA-induced signaling and apoptosisYiguo Zhang, Wei-Ya Ma, Akira Kaji, et al.Carcinogenesis|February 14, 2004
Evidence of STAT1 phosphorylation modulated by MAPKs, MEK1 and MSK1Yiguo Zhang, Yong-Yeon Cho, Brandon L Petersen, et al.Cell Death and Differentiation|June 25, 2026
The emerging roles of alternative splicing in modulating tumor immune responses and immunotherapiesXinyu He, Dengyun Zhao, Yubing Zhou, et al.Cancer Research|April 24, 2012
Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growthDong Joon Kim, Yan Li, Kanamata Reddy, et al.Cancer Research|March 13, 2002
Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetateQing-Bai She, Nanyue Chen, Ann M Bode, et al.Pageof 2,673